Literature DB >> 16611200

Templates for analysis of individual-level prescription data.

Jesper Hallas1, Henrik Støvring.   

Abstract

The advent of large population-based prescription databases has enabled us to study drug use with the individual user as our unit of analysis. This review presents three non-specific analytic templates that may be applied to individual-level prescription data. The ratio of prevalence odds to incidence rate can estimate the average duration for drug use. Limitations and pitfalls are discussed. Although it should be cautiously interpreted, it provides a reasonable ranking of drugs with respect to their retention in users. The Lorenz curve is an analytic tool to express skewness in drug use. It shows the proportion of drug use that is accounted for by percentiles of drug users, ranked according to their volume of drug intake. It may express the extent of heavy users as well as sporadic small-volume users and may, for example, be used to screen for an unsuspected abuse potential of a drug. The waiting-time distribution is a frequency distribution of first occurrences of drug use within a time-window. It forms the basis for a theoretical model for robust estimates of prevalence and incidence rate. On an intuitive level, it displays visual correlates of epidemiological prescribing parameters such as period prevalence, point prevalence, incidence rate, duration, prescription renewal rate, relapse of treatments and seasonality. Each measure may be incorporated into an integral matrix that reflects various traits in utilization of every drug or drug class, thereby possibly finding abnormalities that suggest sub-optimal prescribing.

Mesh:

Substances:

Year:  2006        PMID: 16611200     DOI: 10.1111/j.1742-7843.2006.pto_257.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  19 in total

Review 1.  Abuse Potential of Pregabalin: A Systematic Review.

Authors:  Ole Schjerning; Mary Rosenzweig; Anton Pottegård; Per Damkier; Jimmi Nielsen
Journal:  CNS Drugs       Date:  2016-01       Impact factor: 5.749

2.  Montelukast use-a 19-year nationwide drug utilisation study.

Authors:  Daniel Pilsgaard Henriksen; Jesper Rømhild Davidsen; Christian B Laursen; Anders Christiansen; Per Damkier; Jesper Hallas; Anton Pottegård
Journal:  Eur J Clin Pharmacol       Date:  2017-06-22       Impact factor: 2.953

3.  Driving forces behind increasing cardiovascular drug utilization: a dynamic pharmacoepidemiological model.

Authors:  Helle Wallach Kildemoes; Henrik Støvring; Morten Andersen
Journal:  Br J Clin Pharmacol       Date:  2008-12       Impact factor: 4.335

4.  The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective.

Authors:  Anton Pottegård; Bine Kjøller Bjerregaard; Dorte Glintborg; Jesper Hallas; Søren Ilsøe Moreno
Journal:  Eur J Clin Pharmacol       Date:  2012-03-21       Impact factor: 2.953

5.  Use of Sedatives, Antidepressants and Antipsychotic Medicine among Seventh-day Adventists and Baptists in Denmark.

Authors:  Peter Rasmussen; Christoffer Johansen; Niels Christian Hvidt; Alex Kappel Kørup; Jens Søndergaard; Lau Caspar Thygesen
Journal:  J Relig Health       Date:  2017-10

6.  High concordance between self-reported medication and official prescription database information.

Authors:  Jari Haukka; Jaana Suvisaari; Annamari Tuulio-Henriksson; Jouko Lönnqvist
Journal:  Eur J Clin Pharmacol       Date:  2007-08-22       Impact factor: 2.953

7.  Utilisation of angiotensin receptor blockers in Sweden: combining survey and register data to study adherence to prescribing guidelines.

Authors:  Pia Frisk; Tor-Olov Mellgren; Niklas Hedberg; Anita Berlin; Fredrik Granath; Björn Wettermark
Journal:  Eur J Clin Pharmacol       Date:  2008-08-15       Impact factor: 2.953

8.  Persistence of antimuscarinic drug use.

Authors:  Søren Brostrøm; Jesper Hallas
Journal:  Eur J Clin Pharmacol       Date:  2008-12-24       Impact factor: 2.953

9.  Estimating the empirical Lorenz curve and Gini coefficient in the presence of error with nested data.

Authors:  Chaya S Moskowitz; Venkatraman E Seshan; Elyn R Riedel; Colin B Begg
Journal:  Stat Med       Date:  2008-07-20       Impact factor: 2.373

10.  Regional variation and adherence to guidelines for drug treatment of asthma.

Authors:  Marianne Heibert Arnlind; Björn Wettermark; Mika Nokela; Paul Hjemdahl; Clas Rehnberg; Eva Wikström Jonsson
Journal:  Eur J Clin Pharmacol       Date:  2009-10-14       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.